Clinical trials
Active, not recruiting Phase 2/3 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Bristol-Myers Squibb | 2 |
| Hoffmann-La Roche | 2 |
| Hutchmed | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Tianjin Medical University General Hospital | 2 |
| Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Beijing Pearl Biotechnology Limited Liability Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma, Hepatocellular | 2 |
| Cholangiocarcinoma | 2 |
| Obesity | 2 |
| Recurrence | 2 |
| Adenocarcinoma | 1 |
| Anemia | 1 |
| Carcinoma, Ductal, Breast | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.